e-learning
resources
Madrid 2019
Monday, 30.09.2019
Novel methods, diagnostics and biomarkers in chronic lung diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Prediction of longitudinal inflammatory phenotypes using baseline sputum transcriptomics in UBIOPRED
n. Zounemat Kermani (London, United Kingdom), S. Pavlidis (London, United Kingdom), J. Riley (London, United Kingdom), F. Chung (London, United Kingdom), I. Adcock (London, United Kingdom), Y. Guo (London, United Kingdom)
Source:
International Congress 2019 – Novel methods, diagnostics and biomarkers in chronic lung diseases
Session:
Novel methods, diagnostics and biomarkers in chronic lung diseases
Session type:
Thematic Poster
Number:
2347
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
n. Zounemat Kermani (London, United Kingdom), S. Pavlidis (London, United Kingdom), J. Riley (London, United Kingdom), F. Chung (London, United Kingdom), I. Adcock (London, United Kingdom), Y. Guo (London, United Kingdom). Prediction of longitudinal inflammatory phenotypes using baseline sputum transcriptomics in UBIOPRED. 2347
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: Lung function in epidemiological studies from infancy to childhood with focus on urban environment
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Related content which might interest you:
COPD phenotypes revealed by the integrated sputum microbiome and proteome analysis in COPDMAP cohort
Source: International Congress 2019 – Host-microbe interactions in lung disease and exacerbations
Year: 2019
A multi-omics approach to delineate sputum microbiome-associated asthma inflammatory phenotypes
Source: Eur Respir J, 59 (1) 2102603; 10.1183/13993003.02603-2021
Year: 2022
Concordance in temporally distinct blood and sputum inflammatory phenotypic measures in severe asthma
Source: International Congress 2019 – Clinical implications of asthma management
Year: 2019
Monitoring the inflammatory heterogeneity in asthma with multiple biomarkers for multidimensional endotyping
Source: International Congress 2017 – "Alarming" immunological patterns in asthma
Year: 2017
Longitudinal analysis of sarcoidosis blood transcriptomic signatures and disease outcomes
Source: Eur Respir J 2014; 44: 985-993
Year: 2014
Functional, clinical evolution and cellular inflammatory pattern in induced sputum in patients with difficult-to-control asthma
Source: Annual Congress 2011 - Update on monitoring airway diseases
Year: 2011
Proteomic derived biomarkers for COPD are present in induced sputum
Source: Eur Respir J 2005; 26: Suppl. 49, 439s
Year: 2005
The six-gene expression signature in whole sampled sputum provides clinically feasible inflammatory phenotyping of asthma
Source: ERJ Open Res, 6 (1) 00280-2019; 10.1183/23120541.00280-2019
Year: 2020
A proteomic approach to the progression of COPD: protein expression profile in induced sputum samples
Source: Eur Respir J 2006; 28: Suppl. 50, 824s
Year: 2006
Sputum transcriptomic analysis of air pollutant signatures: link to asthma severity and phenotype
Source: Virtual Congress 2021 – Environment and air pollution
Year: 2021
Biomarkers to identify sputum eosinophilia in different adult asthma phenotypes
Source: Eur Respir J 2015; 46: 688-696
Year: 2015
Plasma metabolomic signature in COPD patients: Associations to proteomic profile and clinical outcomes
Source: Annual Congress 2013 –COPD mechanisms
Year: 2013
Comparative characteristics of induced sputum and brush-biopsy cell counts in COPD exacerbation
Source: Eur Respir J 2005; 26: Suppl. 49, 299s
Year: 2005
Discriminating phenotypes of severe eosinophilic asthma using gene profiling in sputum
Source: International Congress 2018 – Does asthma phenotyping improve treatment?
Year: 2018
Change of biochemical parameters of sputum in patients with different types of COPD exaserbation
Source: Annual Congress 2009 - Exacerbations of COPD and bronchiectasis: aetiology and treatment
Year: 2009
Repeatability of inflammatory analysis in induced sputum samples in COPD
Source: Eur Respir J 2004; 24: Suppl. 48, 469s
Year: 2004
Sputum proteomics identifies distinct endotypes of exacerbations in bronchiectasis
Source: Virtual Congress 2020 – Chronic lung diseases: novel methods, diagnostics and biomarkers
Year: 2020
Blood inflammatory phenotypes of asthma in the Constances cohort
Source: Virtual Congress 2021 – Pearls in asthma and respiratory burden research
Year: 2021
Detailed physiological profiling of patients for a study investigating the airway microbiome
Source: International Congress 2018 – Innovations in equipment and their application
Year: 2018
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept